PDF) WTX101 in patients newly diagnosed with Wilson disease: final

Current and Emerging Issues in Wilson's Disease

PDF) Advances in Treatment of Wilson Disease

IJMS, Free Full-Text

Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect

Full article: Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study - The Lancet Gastroenterology & Hepatology

Diagnosis - Wilson Disease Association

PDF) Wilson's disease: -A Case Report and Review Type of Publication: Case Report.

Aftab ALA, Professor, MBBS MD PhD FRCP, University of Surrey, Guildford, School of Biosciences and Medicine & Department of Health Management and Strategy